首页> 外文期刊>The Journal of Organic Chemistry >Photoredox Catalysis in a Complex Pharmaceutical Setting: Toward the Preparation of JAK2 Inhibitor LY2784544
【24h】

Photoredox Catalysis in a Complex Pharmaceutical Setting: Toward the Preparation of JAK2 Inhibitor LY2784544

机译:复杂药物环境中的光氧化还原催化:制备JAK2抑制剂LY2784544

获取原文
获取原文并翻译 | 示例
       

摘要

We report a detailed investigation into the application of visible light-mediated photocatalysis to a challenging bond construction in a complex pharmaceutical target. The optimized reaction allowed the direct coupling of N-methylmorpholine with an unfunctionalized pyridazine in good yield and selectivity, and with high purity of the product isolated via crystallization. The reaction also facilitated the expedient synthesis of a range of analogues via the use of other commercially available N-methyl substituted tertiary amines, and therefore it represents an attractive tool for medicinal chemistry. Furthermore, a number of other interesting photoredox reactions were discovered during the course of this investigation, such as a formal methylation reaction via C-N bond cleavage, functionalization of C-H bonds alpha to amides, and a visible light-mediated iminium ion reduction.
机译:我们报告了对复杂的药物目标中具有挑战性的债券建设应用可见光介导的光催化的详细调查。优化的反应使N-甲基吗啉与未官能化的哒嗪直接偶联,收率和选择性都很高,并且通过结晶分离出的产物纯度很高。该反应还通过使用其他可商购的N-甲基取代的叔胺促进了一系列类似物的简便合成,因此,它代表了一种用于药物化学的有吸引力的工具。此外,在该研究过程中还发现了许多其他有趣的光氧化还原反应,例如通过C-N键裂解形成的正式甲基化反应,C-H键α与酰胺的官能化以及可见光介导的亚胺离子还原。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号